Aim: Stromelysin 1 (matrix metalloproteinase 3; MMP-3) is an enzyme known to be involved in tumor invasion and metastasis. In this study, fl avonoids from vegetables and fruits, such as quercetin, kaempferol, genistein, genistin, and daidzein, were tested for their ability to modulate the secretion and activity of MMP-3 in the MDA-MB-231 breast cancer cell line. In addition, we investigated the in vitro effects of fl avonoids on MDA-MB-231 cell invasion. Methods: The toxic concentration range of fl avonoids was evaluated using the MTT assay. The ability of MDA-MB-231 cells to invade was evaluated using a modifi ed Boyden chamber system. The activity of MMP-3 was determined by casein zymography. The secretion of MMP-3 was evaluated using Western blotting, casein zymography and confi rmed by ELISA. Results: Some putative fl avonoids, ie, quercetin and kaempferol (fl avonols), signifi cantly inhibited the in vitro invasion of MDA-MB-231 cells in a concentration-dependent manner, with IC 50 values of 27 and 30 μmol/L, respectively. Quercetin and kaempferol also reduced MMP-3 activity in a dose-dependent manner, with IC 50 values in the range of 30 μmol/L and 45 μmol/L, respectively. None of the fl avonoids had a signifi cant effect on the secretion of MMP-3. Conclusion: These data show that the fl avonols quercetin and kaempferol have higher anti-invasion potency and higher MMP-3 inhibitory activity than isofl avones genistein, genistin and daidzein. In contrast, neither fl avonols nor isofl avones have any effect on MMP-3 secretion.
Introduction
Metastatic invasion is the primary cause of patient mortality during breast cancer progression. For a transformed cell to metastasize to a distant site in the body, it must first lose adhesion, penetrate and invade the surrounding extracellular matrix (ECM), enter the vascular system, and adhere to distant organs [1] . The inhibition of invasion of cancer cells has been an important strategy in cancer treatment [2] . A crucial step in the invasive processes is the proteolytic degradation of the ECM and basal membranes [3] . Several studies have shown that among the enzymes responsible for ECM degradation, the matrix metalloproteinases (MMPs) appear to play a critical role [4] [5] [6] . MMPs are zinc-dependent endopeptidases, which collectively can degrade all constituents of the ECM. Based on their structure and substrate specificity, they can be divided into subgroups of collagenases, stromelysins, gelatinases, membrane-type MMPs and other MMPs [7] . Breast cancer is the major cause of malignancy-related deaths of women worldwide. In Thailand, breast cancer is the second most common cancer among women and its incidence is increasing [8] . Cancer invasion and metastasis are leading causes of morbidity and mortality in patients with breast cancer. Several studies have demonstrated that upregulation of MMP-1, -2, -3, -7, -9, -13, and -14 is associated with breast cancer cell invasion [9] [10] [11] . MMP-3, also designated stromelysin 1, is a member of the matrixin family, which plays a pivotal role in the degradation and remodeling of the ECM. MMP-3 degrades several components of the ECM, such as fi bronectin, laminin, collagen type IV [12] [13] [14] and proteoglycans, and is thought to play an important role in rheumatoid arthritis, osteoarthritis [15, 16] , tumor cell invasion and metastasis [17] . Previous studies have demonstrated that the most invasive breast cancers exhibit the highest levels of  [18] . In addition, inhibition of MMP-3 activity with synthetic inhibitors reduces the invasion and migration of various human malignant cell lines [19, 20] . Therefore, every level of regulation of MMP-3 expression and activity has been considered as a possible target for therapeutic intervention [21] . Flavonoids, 2-phenyl-benzo-α-pyrones, are polyphenolic compounds that occur ubiquitously in fruits, vegetables, and plant-derived beverages [22] . These compounds possess a common phenylbenzopyrone structure (C6-C3-C6), with one or more hydroxyl substituents (Figure 1 ). They are categorized (according to the saturation level and opening of the central pyran ring) primarily into fl avonols, fl avones, fl avanols, isofl avones, fl avonones, and fl avanonols. These polyphenolic compounds have several biological activities, which include antimutagenic, antiproliferative and antioxidant effects, as well as involvement in cell signaling, cell cycle regulation and angiogenesis [23] . Furthermore, an increasing number of in vitro and in vivo studies have been conducted on the potential antimetastasis activity of fl avonoids in various tumor cells including human breast cancer. For example, quercetin and genistein have been shown to reduce human breast cancer cell invasion via down-regulation of MMP-1, -2, and -9 expression [24] [25] [26] . In an in vivo study, intraperitoneal administration of quercetin into syngeneic mice resulted in signifi cant inhibition of lung colonization in a dose-dependent manner [27] . Moreover, kaempferol, genistin and daidzein inhibited MDA-MB-231 cell invasion, with a concomitant reduction in the expression of ECM degradation enzymes [28] . However, the correlation between MMP-3 and flavonoids in vitro remains unclear. In the present study we designed experiments to compare the effect of flavonoids in the form of flavonols (quercetin and kaempferol) and isoflavones (genistein, genistin and daidzein) on MMP-3 secretion, MMP-3 activity and invasive activity in MDA-MB-231 human invasive breast cancer cells. Our results demonstrate that the fl avonols quercetin and kaempferol show higher anti-invasion potency and better MMP-3 inhibitory activity than isofl avones.
Materials and methods

Materials
Dulbecco's Modifi ed Eagle's Medium (DMEM) with or without phenol red, penicillin-streptomycin, and trypsin-EDTA was purchased from GIBCO-BRL (Grand Island, NY, USA). Fetal bovine serum was purchased from Hyclone (Logan, Utah, USA). The antibody against MMP-3 was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Matrigel was purchased from Becton Dickinson (Bedford, MA, USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), β-casein, quercetin, kaempferol, genistein, genistin and daidzein were purchased from Sigma-Aldrich (St Louis, MO, USA).
Cell lines and culture conditions MDA-MB-231, a highly invasive breast carcinoma cell, was grown in Leibovitz L-15 medium with 100 U/mL penicillin, 100 μg/mL streptomycin, and 10% heat-inactivated FBS. The cells were grown as a monolayer at 37 o C in a humidified atmosphere without CO 2 . MCF-7, a non-invasive breast carcinoma cell, and NIH3T3 fi broblasts cells were grown in DMEM supplemented with 100 U/mL penicillin, 100 μg/mL streptomycin, and 10% heat-inactivated FBS. Cultures were grown as a monolayer at 37 o C in a 5% CO 2 /95% air atmosphere.
MTT assay for cell viability Cell viability was measured by the conventional MTT reduction assay as previously described [29] . Briefly, MDA-MB-231 cells were inoculated at a density of 5×10 3 cells/well in 96-well plates for 24 h in 100 μL of DMEM with 10% FCS. Following seeding, the culture supernatant was removed and serum-free DMEM medium containing various concentrations of quercetin, kaempferol, genistein, genistin and daidzein was added and the cells were incubated for 24 and 48 h. MTT dye (10 μL, 5 mg/mL) was added to each well and the plate was incubated for an additional 4 h. The absorbance of MTT-formazan was measured using a microplate reader at 540 nm with a 
Cell invasion assay
The invasive behavior of MDA-MB-231 cells was tested using the modifi ed Boyden chamber assay [30] . Polyvinylpyrrolidonefree polycarbonate fi lters (Millipore, Co Cork, Ireland) (8 μm pore sized) were coated with Matrigel (10 μg/filter). The lower chamber contained serum-free conditioned medium from NIH 3T3 fi broblast cells, which acts as a chemoattractant. MDA-MB-231 cells (1.25×10 5 cells/chamber) were plated onto the upper chamber with or without various concentrations of fl avonoids and incubated for 6 h at 37 o C, 5% CO 2 . After incubation, the noninvading cells were removed from the upper surface of the membrane. The invading cells on the lower surface of the membrane were fi xed with methanol for 1 min and stained with toluidine blue for 5 min. The cells that had actively migrated to the underside surface of the filter were dissolved with 20% acetic acid and indirectly quantified by measuring the absorbance at 570 nm. A control experiment was performed in the absence of chemoattractant. The results of duplicate independent experiments were averaged after background subtraction.
Preparation of conditioned media MDA-MB-231 cells (1×10 6 cells) were seeded into a 75-mm 3 T fl ask and maintained for 24 h in DMEM with 10% FBS. Subconfluent cell cultures were incubated for 48 h with various non-toxic concentrations of flavonoids in serum-free DMEM without phenol red. After treatment, the culture supernatant was collected and concentrated with Amicon-Ultra4 (Millipore, Co Cork, Ireland) for further studies.
Casein zymography
To determine MMP-3 activity in conditioned culture medium, MDA-MB-231 cells were incubated in serum-free DMEM without phenol red for 24 h at 37 o C in a 5% CO 2 /95% air atmosphere. The culture supernatant was collected and concentrated with Amicon-Ultra4 (Millipore, Co Cork, Ireland). Ten micrograms of unheated protein from concentrated culture supernatants underwent electrophoresis under nonreducing conditions in 0.2% w/v casein-containing 10% polyacrylamide gels (PAGE) in the presence of SDS. Gels were washed twice for 60 min in 2.5% Triton X 100 to remove SDS and subsequently incubated in Tris buffer (50 mmol/L TrisHCl, 200 mmol/L NaCl, 10 mmol/L CaCl 2 , pH 7.4) in the presence of various concentrations of fl avonoids (0, 5, 25, and 50 μmol/L) and phenantroline 50 μmol/L (positive control) for 48 h at 37 o C. Gels were stained with Coomassie Brilliant Blue R (0.1% w/v) and destained in 30% methanol, 10% acetic acid. Caseinolytic activity appeared as a clear band on a blue background. Digestion bands were quantifi ed by Bio 1 D software (Viber Lourmat, Marne-la-Vallée, France).
To evaluate MMP-3 secretion by casein zymography, MDA-MB-231 cells were incubated in serum-free DMEM without phenol red containing various concentrations of fl avonoids (0, 10, 20, or 30 μmol/L). Ten micrograms of unheated protein from concentrated culture supernatants were subjected to electrophoresis under non-reducing conditions in 0.2% w/v caseincontaining/10% polyacrylamide gels in the presence of SDS. Gels were washed, stained and destained as described above.
Western blot analysis of MMP-3
To investigate the effect of flavonoids on the secretion of MMP-3, Western blot analysis was performed. Equal amounts of concentrated conditioned media proteins from control and treated cells were resuspended in sample buffer and separated by SDS-PAGE, using 10% acrylamide gels. After electrophoresis, proteins were electroblotted to a Hybond-C Extra nitrocellulose membrane (Amersham). The membrane was blocked at room temperature (RT) with 4% BSA in TBST (20 mmol/L Tris pH 7.5, 150 mmol/L NaCl, 0.3% Tween 20) for 2 h. Membranes were further probed with mouse monoclonal antibody against MMP-3 in 4% BSA in TBST (1:200; Santa Cruz Biotechnology, USA) at 4 o C overnight. The blots were washed in TBST and probed with horseradish peroxidase conjugated anti-mouse IgG (1:5,000; Chemicon, France). After incubation, the immunoreactive material was visualized by enhanced chemiluminescence and exposed to X-ray fi lm (Kodak, Windsor, Colorado, USA) for 30−60 min.
MMP-3 ELISA
To further confirm the effect of flavonoids on MMP-3 secretion, human MMP-3 double-sandwiched ELISA was performed using commercial ELISA kits according to the manufacturer's protocol (Calbiochem). Briefly, 50 μL standard dilutions of recombinant human MMP-3 or experimental conditioned media and biotinylated detector monoclonal antibody were aliquoted into a 96-well microtiter plate coated with mouse anti-MMP-3 monoclonal antibody. The plate was sealed, incubated at RT for 2 h, and washed three times with 1×washing buffer; 100 μL diluted horseradish peroxidase conjugated to streptavidin was added and incubated for 30 min at RT and subsequently washed three times. Aliquots of 100 μL of the color reagent 3,3',5,5'-tetramethylbenzidine (TMB) were then applied for 30 min to develop a blue color, and the reaction was stopped by adding 100 μL of 2.5 mol/L sulfuric acid. Absorbance was read at 450 nm by a spectrophotometric plate reader with a reference wavelength of 595 nm.
Statistical analysis
Statistical analyses were performed using one-way ANOVA. P<0.05 or P<0.01 were considered statistically signifi cant. All statistical analyses were performed using SPSS 13.0 software (SPSS, Chicago, IL, USA).
Results
In vitro cytotoxicity assay
The effect of flavonoids on cell viability was measured by the MTT assay. MDA-MB-231 cells treated with the indicated amounts of quercetin, kaempferol and daidzein (0−100 μmol/L) for 48 h showed a concentration-dependent inhibition of cell proliferation. Genistein and genistin did not show Figure 5 ). To confirm these results the experiment was repeated using ELISA (data not shown). For the three methods, all tested fl avonoids had no effect on MMP-3 secretion.
Discussion
Invasiveness or migration through the extracellular matrix (ECM) is a fundamental property of malignant cancer cells. It has been shown that elevated expression of different MMPs is associated with different metastatic stages in the progression of various types of tumors [31] . We found that the level of MMP-3 in MDA-MB-231 (highly invasive breast cancer cells) was four-fold higher than that in MCF-7 (poorly invasive breast cancer cells), suggesting that the expression levels of MMP-3 correlate with the metastatic potential of cancer cells. Elevated levels of MMPs are generally thought to contribute to tumor progression. More recently it has become clear that a complex dual role in tumor progression exists for some MMPs, such as MMP-3 [32] . Conflicting results have been published A recent study showed an acceleration of the growth of lymphoma cells that constitutively express MMP-3 when the cells were injected intrathymically into mice [33] . In contrast, other studies have shown that genetic ablation of MMP-3 does not significantly affect tumor growth and metastasis in the npg MMTV-PyMT model [34] . The transcriptional changes of other MMPs and their specifi c inhibitors in the MMTV-PyMT model may complicate the metastatic outcome. Overall, these results suggest that the expression of a single metalloproteinase, stromelysin 1, is insuffi cient for the progression of mammary adenocarcinomas to an invasive and metastatic phenotype. However, matrix degradation by MMPs can alter the basic processes of cell proliferation and apoptosis.
The chemopreventive effect of the flavonoids, flavonols (quercetin and kaempferol) and isofl avones (genistein, genistin and daidzein) has been observed through the suppression of cell proliferation [35] , inhibition of angiogenesis [36] , inhibition of invasion [37] and stimulation of apoptosis in breast carcinoma cells [38] . The inhibition of invasion of cancer cells is of great significance in cancer treatment. Little is known about the interaction of MMP-3 and flavonoids in human breast carcinoma cells. Therefore, we examined the effects of fl avonoids on MMP-3 secretion, MMP-3 activity and invasive activity using MDA-MB-231 cells in our experiments.
This study examined the effect of fl avonoids on the invasive behavior of MDA-MB-231 using the modifi ed Boyden chamber assay. As shown in Figure 3 , quercetin and kaempferol signifi cantly inhibited the ability of the MDA-MB-231 cells to penetrate the reconstituted basement membrane. In contrast, genistein, genistin and daidzein did not signifi cantly affect cell invasion at high concentrations, suggesting that the fl avonols (quercetin and kaempferol) have higher anti-invasion potency than the isoflavones (genistein, genistin and daidzein). As MMP-3 has been reported to play a role during the migratory and invasive processes of cancer, it is necessary to determine whether fl avonoids can inhibit the invasiveness of tumor cells. Our results help clarify whether fl avonoids can inhibit MMP-3 enzyme activity in MDA-MB-231 cells. Flavonols (quercetin and kaempferol) inhibited the activity of MMP-3. In contrast, (Figure 4 ). In addition, we found that genistein could inhibit MDA-MB-231 cell invasion, but to a lesser extent than quercetin or kaempferol (Figure 3) . However, it seemed to have no effect on the activity of MMP-3 ( Figure 4 ). Possible mechanisms of genistein-mediated inhibition of MDA-MB-231 invasion include down-regulation of the transcription of MMP-2, MMP-9, and MT1-MMP, and up-regulation of tissue inhibitor of metalloproteinase-1 (TIMP-1) [39, 40] . Furthermore, Magee and coworkers [41] demonstrated that other phytoestrogens, including genistein, inhibited MDA-MB-231 cell invasion without affecting cell viability. Consistent with our fi ndings, biofl avonoids used at the concentrations in the cell invasion assay (up to 30 μmol/L) had no effect on cell viability.
MMP proteolytic activity is regulated at three levels: transcription, proenzyme activation, and inhibition. We found that flavonoids (both flavonols and isoflavones) had no effect on MMP-3 secretion ( Figure 5 ). In accordance with these results, quercetin and kaempferol markedly inhibited the caseinolytic activity of MMP-3 and inhibited breast cancer cell invasion, suggesting a relationship between the metastatic potential and MMP-3 activity. Indeed, batimastat (BB-94) and marimastat (BB-2516), two specific inhibitors of MMPs in clinical trials, have been found to reduce tumor metastasis [42] . Inostamycin, an inhibitor of cytidine 5'-diphosphate 1,2-diacyl-sn-glycerol (CDP-DG, inositol transferase), has been found to suppress the invasion of HSC-4 tongue carcinoma cells by reducing the gelatinolytic activities of pro-MMP-9 and pro-MMP-2 [43] . Considering that the dietary fl avonols like quercetin and kaempferol are very safe and exhibit anticancer activities against a wide variety of tumors, we suggest that they can also be used to suppress the progression of the metastatic process in breast carcinoma cells by reducing MMP-3 activity.
